ONCODNA

In News

Precision Oncology Company OncoDNA Closes $20M Series B Financing - Inside Precision Medicine

Inside Precision Medicine - Feb 14, 2020

SYNLAB partners with OncoDNA to provide comprehensive biomarker testing for cancer therapy selection in Germany - SYNLAB

SYNLAB - Mar 29, 2022

OncoDNA raises $8.6M to develop precision oncology IT platforms - Fierce Biotech

Fierce Biotech - Sep 02, 2016

World Cancer Day: Advancing Precision Cancer Care - News-Medical

News-Medical - Feb 04, 2025

OncoDNA and Institut Curie test the clinical utility of personalized liquid biopsy in head and neck cancers - Institut Curie - Espace presse

Institut Curie - Espace presse - Apr 16, 2021

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project - Business Wire

Business Wire - Jan 17, 2024

AI-Powered Cancer Monitoring Test Launched Across Europe - Medical Device and Diagnostic industry

Medical Device and Diagnostic industry - Apr 14, 2022

Sophia Genetics, Realm IDx to pool sequencing tools for cancer care - Fierce Biotech

Fierce Biotech - Mar 14, 2022

Converge Biotech: Embracing The Advancement Of Healthcare Products And The Technologies To Ensure Better Treatment Outcomes - Asia Business Outlook

Asia Business Outlook - Nov 13, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment